The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A genetic variant of 5-hydroxytryptamine receptor 3C (HTR3C): A novel link to chemotherapy-induced side effects.
Tami Rubinek
No relevant relationships to disclose
Dorit Pud
No relevant relationships to disclose
Gil Har-Zahav
No relevant relationships to disclose
Zvi Symon
No relevant relationships to disclose
Yael Laitman
No relevant relationships to disclose
Ido Wolf
No relevant relationships to disclose